[TTC9A表达水平的泛癌分析及其与预后和免疫微环境的相关性]
概括
四重复蛋白9A (TTC9A) 的表达因癌症而异,影响患者的预后和免疫透. 高TTC9A与某些癌症的生存率更好相关,但在其他癌症中更差,表明其复杂的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 四重复蛋白9A (TTC9A) 涉及各种细胞过程.
- 了解TTC9A在癌症中的作用对于开发新的治疗策略至关重要.
研究的目的:
- 为了研究TTC9A在不同类型的瘤中的表达.
- 评估TTC9A表达和患者预后之间的关联.
- 探索TTC9A与瘤中的免疫细胞透之间的关系.
主要方法:
- 利用TCGA和GTEx数据集来分析TTC9A表达,预后,DNA甲基化,瘤突变负担 (TMB) 和微卫星不稳定性 (MSI).
- 使用TIMER和xCell工具来评估TTC9A与免疫透的相关性.
- 在使用西式涂抹和RT-qPCR的癌症细胞系中验证了TTC9A表达.
主要成果:
- 在许多癌症中,TTC9A表达显著改变,肺癌,结肠癌和肝癌细胞系显著增加,膀癌减少.
- 高TTC9A表达与特定癌症 (例如,头角状细胞癌) 的生存率提高相关,但其他癌症 (例如,肺腺癌) 的预后恶化.
- 在大多数癌症类型中,TTC9A表达与免疫细胞透水平有显著的相关性.
结论:
- 在各种癌症中,TTC9A作为一种有价值的预后生物标志物.
- TTC9A的预后意义与瘤突变负担,微卫星不稳定性和免疫细胞透有关.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


